|
2004 Journal Article Nonalcoholic fatty liver disease: is all the fat bad?Clouston, A. D. and Powell, E. E. (2004). Nonalcoholic fatty liver disease: is all the fat bad?. Internal Medicine Journal, 34 (4), 187-191. doi: 10.1111/j.1444-0903.2004.00574.x |
|
2004 Journal Article Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejectionJonsson, Julie R., Gu, Wenyi, Vanags, Daina M., Bishop, G. Alex, McCaughan, Geoffrey W., Fawcett, Jonathon, Lynch, Stephen V., Balderson, Glenda A., Powell, Elizabeth E. and Clouston, Andrew D. (2004). Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection. Liver Transplantation, 10 (3), 397-403. doi: 10.1002/lt.20084 |
|
2004 Journal Article Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional studyBuntain, HM, Greer, RM, Schluter, PJ, Wong, JCH, Batch, JA, Potter, JM, Lewindon, PJ, Powell, E, Wainwright, CE and Bell, SC (2004). Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax, 59 (2), 149-155. doi: 10.1136/thorax.2003.006726 |
|
2004 Journal Article Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injuryWalsh, MJ, Vanags, DM, Clouston, AD, Richardson, MM, Purdie, DM, Jonsson, JR and Powell, EE (2004). Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injury. Hepatology, 39 (5), 1230-1238. doi: 10.1002/hep.20179 |
|
2004 Journal Article CCR5-Delta 32 mutation is strongly associated with primary sclerosing cholangitisEri, R, Jonsson, JR, Pandeya, N, Purdie, DM, Clouston, AD, Martin, N, Duffy, D, Powell, EE, Fawcett, J, Florin, THJ and Radford-Smith, GL (2004). CCR5-Delta 32 mutation is strongly associated with primary sclerosing cholangitis. Genes And Immunity, 5 (6), 444-450. doi: 10.1038/sj.gene.6364113 |
|
2004 Journal Article Chronic hepatitis C and steatosisClouston, A. D., Jonsson, J. R. and Powell, E. (2004). Chronic hepatitis C and steatosis. Current Hepatitis Reports, 3 (4), 123-128. |
|
2004 Journal Article Virus-specific CD8+ T lymphocytes within the normal human liverWard, S. M., Jonsson, J. R., Sierro, S., Clouston, A. D., Lucas, M., Vargas, A. L., Powell, E. E. and Klenerman, P. (2004). Virus-specific CD8+ T lymphocytes within the normal human liver. European Journal of Immunology, 34 (6), 1526-1531. doi: 10.1002/eji.200324275 |
|
2004 Journal Article Association between apolipoprotein E epsilon 4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis CGochee, Peter A., Powell, Elizabeth E., Purdie, David M., Pandeya, Nirmala, Kelemen, Livia, Shorthouse, Claudia, Jonsson, Julie R. and Kelly, Brian (2004). Association between apolipoprotein E epsilon 4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C. Psychosomatics, 45 (1), 49-57. doi: 10.1176/appi.psy.45.1.49 |
|
2004 Journal Article Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of lifeHickman, IJ, Jonsson, JR, Prins, JB, Ash, S, Purdie, DM, Clouston, AD and Powell, EE (2004). Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut, 53 (3), 413-419. doi: 10.1136/gut.2003.027581 |
|
2003 Journal Article In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapyHickman, I. J., Powell, E. E., Prins, J. B., Clouston, A. D., Ash, S., Purdie, D. M. and Jonsson, J. R. (2003). In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. Journal of Hepatology, 39 (6), 1042-1048. doi: 10.1016/S0168-8278(03)00463-X |
|
2003 Journal Article Fatty liver disease: The next epidemic?Hickman, Ingrid and Powell, Elizabeth (2003). Fatty liver disease: The next epidemic?. Medicine Today, 4 (2), 40-47. |
|
2003 Journal Article Steatosis in chronic hepatitis C: Association with increased messenger RNA expression of collagen I, tumor necrosis factor-α and cytochrome P450 2E1Gochee, P. A., Jonsson, J. R., Clouston, A. D., Pandeya, N., Purdie, D. M. and Powell, E. E. (2003). Steatosis in chronic hepatitis C: Association with increased messenger RNA expression of collagen I, tumor necrosis factor-α and cytochrome P450 2E1. Journal of Gastroenterology And Hepatology, 18 (4), 386-392. doi: 10.1046/j.1440-1746.2003.02984.x |
|
2003 Journal Article Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obeseDixon, JB, Bhathal, PS, Jonsson, JR, Dixon, AF, Powell, EE and O'Brien, PE (2003). Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. Journal of Hepatology, 39 (6), 967-971. doi: 10.1016/S0168-8278(03)00459-8 |
|
2003 Journal Article Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001Law M.G., Dore G.J., Bath N., Thompson S., Crofts N., Dolan K., Giles W., Gow P., Kaldor J., Loveday S., Powell E., Spencer J. and Wodak A. (2003). Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. International Journal of Epidemiology, 32 (5), 717-724. doi: 10.1093/ije/dyg101 |
|
2002 Journal Article Lymphocyte apoptosis and cell replacement in human liver allograftsClouston, Andrew D., Jonsson, Julie R., Balderson, Glenda A., Fawcett, Jonathon, Lynch, Stephen V., Kelso, Anne and Powell, Elizabeth E. (2002). Lymphocyte apoptosis and cell replacement in human liver allografts. Transplantation, 73 (11), 1828-1834. doi: 10.1097/00007890-200206150-00022 |
|
2002 Journal Article Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis CHickman, I. J., Clouston, A. D.., Macdonald, G. A., Purdie, D. M., Prins, J. B., Ash, S., Jonsson, J. R. and Powell, E. E. (2002). Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut, 51 (1), 89-94. doi: 10.1136/gut.51.1.89 |
|
2002 Journal Article Interaction of non-alcoholic fatty liver disease with other liver diseasesClouston, AD and Powell, EE (2002). Interaction of non-alcoholic fatty liver disease with other liver diseases. Bailliere's Best Practice and Research in Clinical Gastroenterology, 16 (5), 767-781. doi: 10.1053/bega.2002.0329 |
|
2001 Journal Article Steatosis in chronic hepatitis C: Can weight reduction improve therapeutic efficacy? Authors' replyClouston, Andrew D., Hickman, Ingrid J., Macdonald, Graeme A., Jonsson, Julie R. and Powell, Elizabeth E. (2001). Steatosis in chronic hepatitis C: Can weight reduction improve therapeutic efficacy? Authors' reply. Journal of Hepatology, 35 (3), 433-433. doi: 10.1016/S0168-8278(01)00116-7 |
|
2001 Journal Article Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosisJonsson, Julie R., Clouston, Andrew D., Ando, Yuichi, Kelemen, Livia I., Horn, Murray J., Adamson, Michael D., Purdie, David M. and Powell, Elizabeth E. (2001). Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology, 121 (1), 148-155. doi: 10.1053/gast.2001.25480 |
|
2001 Journal Article Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activationClouston, Andrew D., Jonsson, Julie R., Purdie, David M., Macdonald, Graeme A., Pandeya, Nirmala, Shorthouse, Claudia and Powell, Elizabeth E. (2001). Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. Journal of Hepatology, 34 (2), 314-320. doi: 10.1016/S0168-8278(00)00096-9 |
